SAFETY AND EFFICACY STUDY OF NILOTINIB COMBINED WITH MITOXANTRONE, ETOPOSIDE, AND HIGH-DOSE CYTARABINE INDUCTION CHEMOTHERAPY FOLLOWED BY CONSOLIDATION FOR PATIENTS WITH C-KIT POSITIVE ACUTE MYELOID LEUKEMIA: